Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free
  1. Home
  2. Programs
  3. CME/CE
  4. Strategies for managing hyperkalemia in cardiorenal disease: A clinical dialogue defining a roadmap to improved outcomes

MinuteCE®

Strategies for managing hyperkalemia in cardiorenal disease: A clinical dialogue defining a roadmap to improved outcomes

Challenges of managing hyperkalemia in HF patients with CKD while maintaining RAAS inhibitor therapy

ReachMD Healthcare Image
Restart
Resume

Subtitles available:  English, German, Spanish & more

Choose a format
Take 1 Minute Challenge
1 Minute Challenge Completed
0.75 credits
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Details
Episodes
Presenters
Documents
Comments
  • Overview

    Hyperkalemia is perceived as a barrier to implement guideline-directed medical therapy (GDMT) in patients with cardiorenal disease. In this educational program, a multidisciplinary faculty discusses strategies for managing hyperkalemia in HF patients with CKD while maintaining RAASi therapy.

    This course consists of 3 episodes. Watch all episodes, answer pre- and post-test questions, and start earning CME credits. 

  • Program Highlights

    This educational program consists of 3 presentations on the management of hyperkalemia in cardiorenal disease.

     

    Challenges of managing hyperkalemia in HF patients with CKD while maintaining RAAS inhibitor therapy - Gianluigi Savarese, MD, PhD - Stockholm, Sweden 

    • Gianluigi Savarese discusses the challenges of managing hyperkalemia in patients with HF and CKD. 

     

    An multidisciplinary clinical dialogue: Optimizing long-term goals: practical approaches to novel potassium binder use in cardiorenal care - Aaron Wong, MD (Bridgend, UK) and James Burton, MD (Leicester, UK)

    • A multidisciplinary panel discusses how to optimize long-term goals while managing hyperkalemia in cardiorenal care.

     

    Summarizing multidisciplinary strategies: Where do we go from here? - Gianluigi Savarese, MD, PhD - Stockholm, Sweden 

    • Gianluigi Savarese shares the GUARDIAN-HK recommendations and summarizes the key strategies for navigating hyperkalemia in patients with cardiorenal disease. 
  • Instructions

    • Watch the three lectures and answer the pre- and post-test questions
    • Fill in the evaluation questions
    • Download CME Certificate

    For questions regarding this activity, please contact us at info@pace-cme.org

  • Learning Objectives

    After participating in this educational activity, participants should be better able to: 

    • Identify the risk factors for hyperkalemia in patients with cardiorenal disease
    • Analyze data on the use of novel potassium binders for hyperkalemia management
    • Discuss and consider strategies for optimizing renin-angiotensin-aldosterone system inhibitor (RAASi) use in patients with cardiorenal disease, despite challenges such as hyperkalemia
    • Reproduce findings from studies on the interplay between hyperkalemia, RAASi use, and clinical outcomes   
  • Target Audience

    This activity has been designed to meet the educational needs of cardiologist and nephrologists as well as all other physicians, physician assistants, nurse practitioners, nurses, pharmacists, and healthcare providers involved in managing patients with hyperkalemia.

  • Accreditation and Credit Designation Statements

    This enduring activity is accredited by the European Board for Accreditation of Continuing Education for Health Professional (EBAC) for 39 minutes of effective education time.

    Through an agreement between EBAC and the American Medical Association, physicians may convert EBAC External CME credits to AMA PRA Category 1 Credits™. Information on the process to convert EBAC credit to AMA credit can be found on the AMA website. Other health care professionals may obtain from the AMA a certificate of having participated in an activity eligible for conversion of credit to AMA PRA Category 1 Credit™. 

  • Provider(s)/Educational Partner(s)

    Today’s healthcare environment is constantly evolving and advances of medical science occur at an accelerating pace. CME/CE plays an important role in the clinical environment and is an essential element of physician training, learning, and improvement, thereby importantly contributing to optimal patient care. Since 2000, MEDCON’s mission is to deliver high quality within the world of medical education by creating forums like PACE-CME, organizing live meetings, and providing online education.  We aim to stimulate the review, exchange, and assimilation of key scientific findings to improve patients’ health, to raise awareness of new science underlying various disease states, and to accelerate the translation of this information into clinical practice. 

  • Commercial Support

    Funding for this educational program was provided by an unrestricted educational grant from AstraZeneca. 

  • Disclaimer

    The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of PACE-CME. 

  • System Requirements

    • Supported Browsers (2 most recent versions):
      • Google Chrome for Windows, Mac OS, iOS, and Android
      • Apple Safari for Mac OS and iOS
      • Mozilla Firefox for Windows, Mac OS, iOS, and Android
      • Microsoft Edge for Windows
    • Recommended Internet Speed: 5Mbps+

  • Publication Dates

    Release Date:

    Expiration Date:

Schedule9 Dec 2024